Significance of transcriptionally-active high-risk human papillomavirus in sinonasal squamous cell carcinoma: Case series and a meta-analysis.


Journal

Neoplasma
ISSN: 0028-2685
Titre abrégé: Neoplasma
Pays: Slovakia
ID NLM: 0377266

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 30 03 2020
accepted: 01 07 2020
pubmed: 28 8 2020
medline: 26 1 2021
entrez: 28 8 2020
Statut: ppublish

Résumé

Sinonasal cancers represent a highly heterogeneous group of head and neck cancers, for which etiological and prognostic significance of high-risk human papillomavirus (HPV) infections has not yet been conclusively established. We investigated the presence of transcriptionally-active high-risk HPV in a series of 34 sinonasal squamous cell cancer (SNSCC) cases and evaluated the effect of transcriptionally-active HPV on the overall survival. In addition, we performed a meta-analysis of previously published studies, including this study, to summarize the prevalence of HPV positivity across histological subtypes of SNSCC. The presence of transcriptionally-active HPV was detected by HPV mRNA using the polymerase chain reaction (PCR) or in situ hybridization (ISH). p16 expression was evaluated as a surrogate marker for transcriptionally-active HPV infection by immunohistochemistry (IHC), the presence of high-risk HPV DNA was tested by PCR and the HPV genotypes were determined by sequencing of PCR amplicons. Transcriptionally-active HPV infections were found in ~25% of the SNSCC cases. The role of HPV infection in keratinizing SNSCC may be higher than previously reported (~32% in our study vs. ~0-6.3% in all other studies). Patients with transcriptionally-active HPV-positive SNSCCs were more likely to be diagnosed at earlier stages (p<0.05) and displayed better mean overall survival, although the difference between HPV-positive and HPV-negative groups was not statistically significant. In contrast to other non-oropharyngeal squamous cell carcinomas (non-OPSCCs) of the head and neck, in SNSCCs, p16/IHC and p16/IHC+HPV DNA displayed high specificity as surrogate markers of transcriptionally-active HPV infections. However, p16/IHC may have significantly lower sensitivity as a surrogate marker of transcriptionally-active HPV in SNSCCs compared to OPSCCs. Furthermore, in our group of SNSCCs, all cases positive for high-risk HPV DNA by PCR were also transcriptionally-active (causative) infections with positive HPV mRNA by ISH. Our results imply a possible different role of HPV-mediated carcinogenesis of squamous cell epithelium in oropharyngeal and sinonasal sites with the latter displaying a lower proportion of causative HPV infections; nevertheless, most cases positive for high-risk HPV DNA, p16/IHC or combination thereof were also found positive for transcriptionally-active HPV. The prognostic significance of HPV status in SNSCCs remains inconclusive and future studies should investigate the presence of transcriptionally-active HPV by direct HPV testing.

Identifiants

pubmed: 32853018
doi: 10.4149/neo_2020_200330N332
pii: 200330N332
doi:
pii:

Substances chimiques

Biomarkers, Tumor 0
CDKN2A protein, human 0
Cyclin-Dependent Kinase Inhibitor p16 0
DNA, Viral 0
RNA, Viral 0

Types de publication

Journal Article Meta-Analysis

Langues

eng

Sous-ensembles de citation

IM

Pagination

1456-1463

Auteurs

M Svajdler (M)

Sikl's Department of Pathology, The Faculty of Medicine and Faculty Hospital in Pilsen, Charles University, Pilsen, Czech Republic.
Biopticka laborator, s.r.o., Pilsen, Czech Republic.

J Nemcova (J)

Sikl's Department of Pathology, The Faculty of Medicine and Faculty Hospital in Pilsen, Charles University, Pilsen, Czech Republic.
Biopticka laborator, s.r.o., Pilsen, Czech Republic.

P Dubinsky (P)

Department of Radiation Oncology, Oncology Institute, Kosice, Slovakia.

A Metelkova (A)

Department of Oncology and Radiotherapeutics, The Faculty of Medicine and Faculty Hospital in Pilsen, Charles University, Pilsen, Czech Republic.

P Svajdler (P)

Louis Pasteur University Hospital, Kosice, Slovakia.
Cytopathos s.r.o., Bratislava, Slovakia.

Ľ Straka (Ľ)

Klinicka patologia Presov, s.r.o., Presov, Slovakia.

R Sakar (R)

Department of Otorhinolaryngology, The Faculty of Medicine and Faculty Hospital in Pilsen, Charles University, Pilsen, Czech Republic.

O Daum (O)

Sikl's Department of Pathology, The Faculty of Medicine and Faculty Hospital in Pilsen, Charles University, Pilsen, Czech Republic.
Biopticka laborator, s.r.o., Pilsen, Czech Republic.

M Michal (M)

Sikl's Department of Pathology, The Faculty of Medicine and Faculty Hospital in Pilsen, Charles University, Pilsen, Czech Republic.
Biopticka laborator, s.r.o., Pilsen, Czech Republic.

A Skalova (A)

Sikl's Department of Pathology, The Faculty of Medicine and Faculty Hospital in Pilsen, Charles University, Pilsen, Czech Republic.
Biopticka laborator, s.r.o., Pilsen, Czech Republic.

R Mezencev (R)

School of Biological Sciences, Georgia Institute of Technology, Atlanta, Georgia, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH